Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,563 | -1,460 | -1,494 | -1,113 | -1,523 |
| Depreciation Amortization | 310 | 366 | 242 | 120 | 39 |
| Income taxes - deferred | 419 | N/A | N/A | N/A | N/A |
| Accounts receivable | -181 | 1,007 | -1,739 | -2,425 | N/A |
| Accounts payable and accrued liabilities | 624 | 1,174 | 1,856 | 2,176 | 552 |
| Other Working Capital | 5,702 | 2,181 | 117 | -249 | 272 |
| Other Operating Activity | -443 | -2,181 | -117 | 249 | -426 |
| Operating Cash Flow | $3,868 | $1,087 | $-1,135 | $-1,242 | $-1,086 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -120 | -101 | -121 | -100 | N/A |
| Purchase Sale Intangibles | -66 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -66 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-186 | $-101 | $-121 | $-100 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -2,315 | -164 | 1,791 | 1,614 | 50 |
| Debt Repayment | -1,208 | -852 | -580 | -289 | N/A |
| Other Financing Activity | -200 | -8 | -6 | -4 | 0 |
| Financing Cash Flow | $-3,723 | $-1,024 | $1,205 | $1,321 | $50 |
| Beginning Cash Position | 52 | 51 | 51 | 51 | 1,341 |
| End Cash Position | 11 | 13 | N/A | 30 | 305 |
| Net Cash Flow | $-41 | $-38 | $-51 | $-21 | $-1,036 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,868 | 1,087 | -1,135 | -1,242 | -1,086 |
| Capital Expenditure | -120 | -101 | -121 | -100 | N/A |
| Free Cash Flow | 3,748 | 986 | -1,256 | -1,342 | -1,086 |